The company asserted that it has published as many as 9 research studies on the safety and efficacy of Covaxin in five reputed peer-reviewed journals in a span of 12 months.
Bharat Biotech's US partner for Covaxin Ocugen Thursday said it will pursue full approval through a Biologics License Application, which may delay the vaccine launch in the country.
Bharat Biotech’s statement comes at a time when the country is facing a shortage of Covid vaccines, leading to disruptions in the nationwide inoculation programme.
Duration of the emergency use listing process depends on the quality of the data submitted by the vaccine manufacturer and on those data meeting WHO criteria, according to the agency.
The trials would be on children aged 2-18 years for which Bharat Biotech may get the licence in the third quarter of this year, a FICCI Ladies Organisation press release Sunday said.
Team collected blood samples of patients who had recovered from Covid along with those who had been vaccinated with Covaxin. But experts say lab tests aren’t enough.
Citing a study published in a peer-reviewed medical journal, Bharat Biotech said noted that vaccination with Covaxin produced neutralising titers against all key emerging variants.
Countering insurgency needs the Pakistan Army to demonstrate a political will that ties leaders at the centre with those in the borderlands. But it may not have the imagination.
Centre for Science and Environment in new report makes case for rationalising GST on waste material, saying most informal operators can’t afford high tax & it also hinders recycling.
21st edition of annual joint military exercise will be held from 1 to 16 September, aimed at sharing military tech, operational best practices & disaster relief coordination methods.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS